Keywords: merck, kgaa, 2nd-qtr, profit, surges, up, darmstadt
Merck KGaA's 2nd-qtr profit surges up 113%
Article | 31 July 2006
Darmstadt, Germany-headquartered Merck KGaA says that its second-quarter 2006 sales rose 4.5% on the comparable period last year to 1.52 billion euros ($1.92 billion), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
